Deodato, Francesco
 Distribuzione geografica
Continente #
EU - Europa 5.603
NA - Nord America 5.083
AS - Asia 1.863
AF - Africa 60
SA - Sud America 41
OC - Oceania 10
Continente sconosciuto - Info sul continente non disponibili 8
Totale 12.668
Nazione #
US - Stati Uniti d'America 5.008
DE - Germania 2.297
SE - Svezia 1.122
CN - Cina 784
SG - Singapore 565
IT - Italia 520
UA - Ucraina 497
IE - Irlanda 270
FR - Francia 245
GB - Regno Unito 195
ID - Indonesia 171
FI - Finlandia 156
IN - India 135
RU - Federazione Russa 102
TR - Turchia 72
CA - Canada 70
BE - Belgio 49
CI - Costa d'Avorio 49
IR - Iran 32
JP - Giappone 32
CZ - Repubblica Ceca 27
BR - Brasile 24
NL - Olanda 24
HK - Hong Kong 23
VN - Vietnam 17
ES - Italia 13
CH - Svizzera 12
LT - Lituania 11
RO - Romania 11
AT - Austria 10
AU - Australia 8
CL - Cile 7
EG - Egitto 7
DK - Danimarca 5
EU - Europa 5
RS - Serbia 5
GR - Grecia 4
LK - Sri Lanka 4
PT - Portogallo 4
BG - Bulgaria 3
EC - Ecuador 3
HR - Croazia 3
HU - Ungheria 3
KZ - Kazakistan 3
LU - Lussemburgo 3
MA - Marocco 3
NO - Norvegia 3
PE - Perù 3
PH - Filippine 3
PL - Polonia 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AE - Emirati Arabi Uniti 2
AM - Armenia 2
AR - Argentina 2
AZ - Azerbaigian 2
BO - Bolivia 2
IL - Israele 2
JM - Giamaica 2
KG - Kirghizistan 2
MK - Macedonia 2
MY - Malesia 2
NZ - Nuova Zelanda 2
SA - Arabia Saudita 2
TW - Taiwan 2
A1 - Anonimo 1
AG - Antigua e Barbuda 1
BD - Bangladesh 1
BZ - Belize 1
EE - Estonia 1
KW - Kuwait 1
LA - Repubblica Popolare Democratica del Laos 1
MD - Moldavia 1
MU - Mauritius 1
MX - Messico 1
NP - Nepal 1
SI - Slovenia 1
SK - Slovacchia (Repubblica Slovacca) 1
TH - Thailandia 1
UZ - Uzbekistan 1
Totale 12.668
Città #
Chandler 1.233
Singapore 431
Ashburn 375
Jacksonville 286
Dublin 267
San Mateo 258
Nanjing 179
Wilmington 171
Jakarta 169
Dearborn 160
Boston 125
Bremen 125
Nürnberg 114
Milan 111
New York 104
Woodbridge 103
Beijing 97
Marseille 97
Ann Arbor 96
Lawrence 81
Cattolica 79
Princeton 77
Izmir 68
Moscow 67
Nanchang 65
Helsinki 64
Fairfield 60
Houston 56
Redwood City 55
Rome 53
Abidjan 49
Brussels 49
Munich 48
Seattle 47
Los Angeles 45
Leawood 33
Toronto 33
University Park 33
Zhengzhou 33
Fremont 31
Kunming 31
Shenyang 31
Augusta 30
Phoenixville 29
Norwalk 28
Redmond 28
Hebei 26
Mountain View 24
Boardman 23
Jiaxing 23
Tianjin 22
Lancaster 21
North York 21
Detroit 20
Auburn Hills 19
Changsha 19
Falls Church 19
Shanghai 19
Guangzhou 18
Pune 18
Cambridge 17
Hangzhou 17
Hanoi 14
Brno 13
Chicago 13
London 12
Amsterdam 11
Andover 11
Frankfurt am Main 11
Monmouth Junction 11
Ardabil 10
Edinburgh 10
Lanzhou 10
Nuremberg 10
Washington 10
Berlin 9
Falkenstein 9
Hefei 9
Hong Kong 9
Bologna 8
Kish 8
Sacramento 8
Central District 7
Indiana 7
Ningbo 7
Ottawa 7
San Francisco 7
Tokyo 7
Vienna 7
Bari 6
Chengdu 6
Florence 6
Jinan 6
Phoenix 6
Saint Paul 6
Sergii 6
Simi Valley 6
Cairo 5
Costa Mesa 5
Latina 5
Totale 6.448
Nome #
Results of a phase II study of Short-course Accelerated Radiation Therapy (SHARON) for multiple brain metastases 254
Mammography before post-operative radiotherapy in conservatively managed breast cancer patients: is it useful? 169
Chemoradiation and brachytherapy in biliary tract carcinoma - Long-term results 149
Volumetric modulated arc therapy with simultaneous integrated boost for locally advanced rectal cancer 147
Applicator-guided volumetric-modulated arc therapy for low-risk endometrial cancer 144
Chemoradiation and brachytherapy in extrahepatic bile duct carcinoma 143
Radioprotective effect of moderate wine consumption in patients with breast carcinoma. 141
Long-term Analysis of Gemcitabine-based Chemoradiation after Surgical Resection for Pancreatic Adenocarcinoma 140
Short-Course Accelerated Radiotherapy in Palliative Treatment of Advanced Pelvic Malignancies: A Phase I Study 139
Planning comparison between standard and conformal 3D techniques in post-operative radiotherapy of gastric cancer: a systematic review 139
Intraluminal brachytherapy without stenting in intrahepatic papillary cholangiocarcinoma: a case report 134
Postoperative intensity modulated radiation therapy in high risk prostate cancer: a dosimetric comparison 134
A systematic review of resectability and survival after concurrent chemoradiation in primarily unresectable pancreatic cancer. 133
Long-term analysis of gemcitabine-based chemoradiation after surgical resection for pancreatic adenocarcinoma 133
Capecitabine based postoperative accelerated chemoradiation of pancreatic carcinoma. A dose-escalation study. 131
Phase I-II studies on accelerated IMRT in breast carcinoma: technical comparison and acute toxicity in 332 patients. 131
Postoperative intensity modulated radiation therapy in high risk prostate cancer: A dosimetric comparison. 130
Clinical target volume delineation including elective nodal irradiation in preoperative and definitive radiotherapy of pancreatic cancer 129
Intensity-modulated radiotherapy with simultaneous integrated boost to dominant intraprostatic lesion: preliminary report on toxicity 129
Applicator-guided volumetric-modulated arc therapy for low-risk endometrial cancer 129
Accelerated intensity-modulated radiotherapy plus temozolomide in patients with glioblastoma: a phase I dose-escalation study (ISIDE-BT-1) 129
Volumetric intensity modulated arc therapy for stereotactic body radiosurgery in oligometastatic breast and gynecological cancers: feasibility and clinical results 129
Stereotactic radiosurgery (SRS) with volumetric modulated arc therapy (VMAT): interim results of a multi-arm phase I trial (DESTROY-2) 126
Quality of life and toxicity of stereotactic radiotherapy in pancreatic tumors: a case series 123
Endocavitary in vivo dosimetry for IMRT treatments of gynecologic tumors 122
Early radiation-induced mucosal changes evaluated by proctoscopy: Predictive role of dosimetric parameters 120
A phase I study of short-course accelerated whole brain radiation therapy for multiple brain metastases 120
Adjuvant volumetric-modulated arc therapy with simultaneous integrated boost in endometrial cancer. Planning and toxicity comparison 117
Postoperative intensity-modulated radiotherapy with simultaneous integrated boost in prostate cancer: A dose-escalation trial 116
Concomitant boost radiotherapy and multidrug chemotherapy in the neoadjuvant treatment of locally advanced rectal cancer: results of a phase II study 115
Eccrine Syringofibroadenoma radiation treatment of an unusual presentation 114
Preoperative Chemoradiation With VMAT-SIB in Rectal Cancer: A Phase II Study 113
Early proctoscopy is a surrogate endpoint of late rectal toxicity in prostate cancer treated with radiotherapy 112
Hypofractionated intensity-modulated radiotherapy with simultaneous integrated boost after radical prostatectomy: preliminary results of a phase II trial 112
Incidence and management of noncancer pain in cancer patients referred to a radiotherapy center 112
Postoperative intensity modulated radiation therapy in high risk prostate cancer: a dosimetric comparison 111
FOLFIRI-bevacizumab and concurrent low-dose radiotherapy in metastatic colorectal cancer: preliminary results of a phase I-II study 109
In Vivo Portal Dosimetry by an Ionization Chamber 108
Radiotherapy and concurrent metronomic chemotherapy in hormone-refractory prostate carcinoma: a Phase I study 107
3D conformal postoperative radiotherapy with concomitant boost in uterine cancer: results of a phase I-II study (ADA-RT-1) 105
Forward planned intensity modulated radiotherapy (IMRT) for whole breast postoperative radiotherapy. Is it useful? When? 104
Adjuvant Chemoradiation in Pancreatic Cancer: A Pooled Analysis in Elderly (≥75 years) Patients 103
Radiochemotherapy with Gemcitabine in Unresectable Extrahepatic Cholangiocarcinoma: Long-term Results of a Phase II Study 103
Extracranial radiosurgery with volumetric modulated arc therapy: Feasibility evaluation of a phase I trial 102
Forward-planned intensity modulated radiation therapy using a cobalt source: A dosimetric study in breast cancer 102
Concomitant boost dose escalation plus large-field preoperative chemoradiation in locally advanced carcinoma of the uterine cervix: results of a phase I study (LARA-CC-1). 100
Short-course radiotherapy in elderly patients with early stage non-melanoma skin cancer: a phase II study 100
Prolonged chemoradiation in locally advanced carcinoma of the uterine cervix: final results of a phase ii study (ester-1). 98
Assessing the feasibility of volumetric-modulated arc therapy using simultaneous integrated boost (SIB-VMAT): An analysis for complex head-neck, high-risk prostate and rectal cancer cases 98
Postoperative intensity-modulated radiotherapy with simultaneous integrated boost in prostate cancer: A dose-escalation trial 97
Phase I-II studies on accelerated IMRT in breast carcinoma: Technical comparison and acute toxicity in 332 patients. 97
A phase I dose-escalation study (iside-bt-1) of accelerated imrt with temozolomide in patients with glioblastoma. 95
3D conformal postoperative radiotherapy with concomitant boost in uterine cancer: results of a phase I-II study (ADA-RT-1) 95
Postoperative intensity modulated radiation therapy in high risk prostate cancer: a dosimetric comparison 95
Stereotactic radiotherapy in recurrent gynecological cancer: a case series 93
Initial clinical experience with Epid-based in-vivo dosimetry for VMAT treatments of head-and-neck tumors 92
Real time transit dosimetry for the breath-hold radiotherapy technique experience 89
Prolonged chemoradiation in locally advanced carcinoma of the uterine cervix: final results of a phase II study (ESTER-1). 89
Concomitant boost plus large-field preoperative chemoradiation in locally advanced uterine cervix carcinoma: Phase II clinical trial final results (LARA-CC-1) 89
Radioprotective effect of calcium channel blockers against late rectal bleeding in prostate cancer 89
Low-dose radiotherapy and concurrent FOLFIRI-bevacizumab: A Phase II study 87
Neoadjuvant Accelerated Concomitant Boost Radiotherapy and Multidrug Chemotherapy in Locally Advanced Rectal Cancer: A Dose-Escalation Study 87
Synchronous male carcinoma of the breast, exocrine pancreas, and prostate 86
Hypofractionated intensity-modulated radiotherapy with simultaneous integrated boost after radical prostatectomy: Preliminary results of a phase II trial 86
Complexity index (COMIX) and not type of treatment predicts undetected errors in radiotherapy planning and delivery. 84
Active Breathing Coordinator in adjuvant three-dimensional conformal radiotherapy of early stage breast cancer: a feasibility study. 84
Palliative two-dimensional radiotherapy of pancreatic carcinoma: a feasibility study. 83
Palliative short-course radiation therapy in rectal cancer: A phase 2 study 83
Intensity Modulated Radiation Therapy With Simultaneous Integrated Boost in Patients With Brain Oligometastases: A Phase 1 Study (ISIDE-BM-1) 83
Volumetric modulated arc therapy (VMAT) and simultaneous integrated boost in head-and-neck cancer: Is there a place for critical swallowing structures dose sparing? 80
A Large, Multicenter, Retrospective Study on Efficacy and Safety Of Stereotactic Body Radiotherapy (SBRT) in Oligometastatic Ovarian Cancer (MITO RT1 Study): A Collaboration of MITO, AIRO GYN, and MaNGO Groups 80
Intensity-modulated extended-field chemoradiation plus simultaneous integrated boost in the pre-operative treatment of locally advanced cervical cancer: a dose-escalation study 79
Concurrent Chemoradiation with Concomitant Boost in Locally Advanced Rectal Cancer: A Phase II Study 78
Simultaneous Integrated Boost Volumetric Modulated Arc Therapy in the Postoperative Treatment of High-Risk to Intermediate-Risk Endometrial Cancer: Results of ADA II Phase 1-2 Trial 78
18 F-FDG Pet-Guided External Beam Radiotherapy in Iodine-Refractory Differentiated Thyroid Cancer: A Pilot Study 77
Optimal beam margins in linac-based VMAT stereotactic ablative body radiotherapy: A Pareto front analysis for liver metastases 77
Feasibility Study Of Moderately Accelerated Intensity-Modulated Radiotherapy Plus Concurrent Weekly Cisplatin After Induction Chemotherapy In Locally Advanced Head-And Neck Cancer. 76
Linac-based extracranial radiosurgery with Elekta volumetric modulated arc therapy and an anatomy-based treatment planning system: Feasibility and initial experience 74
INTERACTS (INTErventional Radiotherapy ACtive Teaching School) guidelines for quality assurance in choroidal melanoma interventional radiotherapy (brachytherapy) procedures 73
INTERACTS (INTErventional Radiotherapy ACtive Teaching School) guidelines for quality assurance in choroidal melanoma interventional radiotherapy (brachytherapy) procedures 73
A Phase I study of high-dose-rate intraluminal brachytherapy as palliative treatment in extrahepatic biliary tract cancer 73
Interventional radiotherapy as exclusive treatment for primary nasal vestibule cancer: Single-institution experience 73
Cervical cancer patterns of care in Italy: A radiation oncology survey of MITO and AIRO GYN groups 71
A phase I dose-escalation study (ISIDE-BT-1) of accelerated IMRT with temozolomide in patients with glioblastoma. 70
Videoconferencing to enhance the integration between clinical medicine and teaching: a feasibility study 70
Progestin-releasing intrauterine device insertion plus palliative radiotherapy in frail, elderly uterine cancer patients unfit for radical treatment 70
Pain REduction with bone metastases STereotactic radiotherapy (PREST): A phase III randomized multicentric trial 70
Predictive Factors of Late-onset Rectal Mucosal Changes After Radiotherapy of Prostate Cancer 69
Individually optimized stereotactic radiotherapy for pancreatic head tumors: A planning feasibility study 68
A Large, Multicenter, Retrospective Study on Efficacy and Safety of Stereotactic Body Radiotherapy (SBRT) in Oligometastatic Ovarian Cancer (MITO RT1 Study): A Collaboration of MITO, AIRO GYN, and MaNGO Groups 68
Forward planned intensity modulated radiotherapy (IMRT) for whole breast postoperative radiotherapy. Is it useful? When? 67
Daily on-line set-up correction in 3D-conformal radiotherapy: is it feasible? 67
The INTERACT Trial: Long-term results of a randomised trial on preoperative capecitabine-based radiochemotherapy intensified by concomitant boost or oxaliplatin, for cT2 (distal)-cT3 rectal cancer 67
Efficacy and safety of stereotactic body radiotherapy (SBRT) in oligometastatic/persistent/recurrent ovarian cancer: a prospective, multicenter phase II study (MITO-RT3/RAD) 67
A Phase I study of high-dose-rate intraluminal brachytherapy as palliative treatment in extrahepatic biliary tract cancer 66
An atlas for clinical target volume definition, including elective nodal irradiation in definitive radiotherapy of biliary cancer 65
Concomitant boost plus large-field preoperative chemoradiation in locally advanced uterine cervix carcinoma: Phase II clinical trial final results (LARA-CC-1) 62
Short course accelerated radiation therapy (SHARON) in palliative treatment of advanced solid cancer in older patients: A pooled analysis 61
Adjuvant chemoradiation in pancreatic cancer: impact of radiotherapy dose on survival 61
Postoperative intensity-modulated radiotherapy with simultaneous integrated boost in prostate cancer: A dose-escalation trial 60
Totale 10.081
Categoria #
all - tutte 57.745
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 57.745


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020608 0 0 0 0 0 0 0 53 146 95 213 101
2020/2021948 34 98 16 94 139 44 108 27 128 70 155 35
2021/20221.513 139 87 21 107 119 51 25 224 58 116 283 283
2022/20233.480 472 477 243 584 207 404 189 277 394 41 144 48
2023/20241.424 66 422 57 110 38 158 92 118 13 44 193 113
2024/20251.064 73 80 208 112 348 76 58 109 0 0 0 0
Totale 12.836